A new study suggests that a subtle change in walking speed may be one of the earliest silent warning signs of cognitive ...

Long-term Phase 1/2a and open label extension (OLE) data for zorevunersen on top of standard of care anti-seizure medicines (ASMs)demonstrate ...

—Long-term Phase 1/2a and open label extension (OLE) data for zorevunersen on top of standard of care anti-seizure medicines (ASMs) demonstrate durable seizure reductions, including increases in ...

Stoke Therapeutics, Inc. , a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine, and Biogen Inc. today announced data presentations ...

Many people live with a secret that feels almost impossible to describe. They hear speech or whispers that nobody else detects. These are not vague impressions. They can feel as solid as a friend ...

In every way, Taylor Hyma, 18, was a “normal teen.” She went to school, worked, hung out with friends, and took care of herself. Then suddenly, her life began to ...

A new advance from Carnegie Mellon University researchers could reshape how clinicians identify the brain regions responsible ...

A new advance from Carnegie Mellon University researchers could reshape how clinicians identify the brain regions responsible for drug-resistant epilepsy.

A 4-channel wearable seizure detection algorithm performance approaches the level of expert epileptologists for the detection of electrographic seizures.

The AAN’s first-ever functional seizure guideline targets stigma and unnecessary treatment, offering clearer diagnostic steps ...

Psilocybin is a psychedelic drug with promising clinical applications for treating mood disorders and substance abuse ...